Search for: "Hatch v Hatch"
Results 141 - 160
of 1,284
Sorted by Relevance
|
Sort by Date
29 Apr 2010, 6:37 pm
Enter Stengart v. [read post]
27 Apr 2010, 9:59 pm
But the statutory language at issue involved the 2003 Medicare Prescription Drug Improvement and Modernization Act, which amended the 1984 Drug Price Competition and Patent Term Restoration Act (colloquially known as the Hatch-Waxman Act), thus raising the opinion's significance. [read post]
17 Dec 2008, 5:54 am
By Donald Zuhn --Last week, the Federal Circuit affirmed a finding of exceptionality and award of $16.8 million in attorneys fees by the District Court for the Southern District of New York in a case involving two Hatch-Waxman challenges to U.S. [read post]
21 Aug 2009, 2:40 pm
The mock trial, Newark Branded Pharmaceuticals v. [read post]
3 Jul 2018, 7:13 am
On May 23, 2018, the Federal Circuit issued a decision in UCB, Inc. v. [read post]
1 May 2012, 10:00 pm
Register for the one hour briefing on Caraco v. [read post]
6 Oct 2010, 10:01 pm
Teva v. [read post]
20 Feb 2013, 7:37 am
Bristol-Myers Squibb Company v. [read post]
14 Feb 2013, 9:59 pm
Indeed, the current squabble over "reverse payment" settlement agreements of lawsuits under the ANDA provisions of the Hatch-Waxman Act (codified at 35 U.S.C. [read post]
24 Jun 2020, 8:52 am
The court today denied two en banc petitions: Biogen International GmbH v. [read post]
8 Oct 2020, 9:59 pm
Noonan -- The back-and-forth, (almost) cat-and-mouse-like competition between branded innovator and generic drug makers sanctioned under the Hatch-Waxman Act has been on-going for over thirty years. [read post]
1 Feb 2022, 6:41 pm
The crewmember was injured when a hatch closed on him. [read post]
24 Feb 2009, 2:04 pm
Eli Lilly & Co. v. [read post]
18 Aug 2020, 1:15 pm
April 21, 2020) (Biogen v. [read post]
8 Feb 2011, 7:19 am
" Sanofi-Aventis Deutschland GMBH, et. al. v. [read post]
24 Apr 2014, 9:59 pm
In this Hatch-Waxman litigation, the plaintiffs (patent owners and licensees) brought suit after the defendants filed an ANDA with a paragraph IV certification alleging that the claims of plaintiffs' patent 5,721,244 ("'244 patent") were obvious. [read post]
20 Aug 2020, 9:59 pm
Noonan -- ANDA litigation, pursuant to the Hatch-Waxman Act, has become more complicated over the years since enactment of the statute in 1984, with more patents being asserted and more parties participating over the opportunity to market a generic version of a branded, innovator drug. [read post]
4 Apr 2020, 5:47 am
Stark in Belcher Pharmaceutical, LLC v. [read post]
23 Feb 2015, 12:46 pm
Perhaps they all want to see where the others stands before opening the escape hatch. [read post]
7 Aug 2012, 7:43 pm
Supreme Court’s decision in Merck KGaA v. [read post]
